Omnicell has been focused on protecting inventions in United States(US) with five publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 44% grants. The United States(US), Australia(AU), South Korea(KR), and China(CN) patent Office are among the top ten patent offices where Omnicell is filings its patents. Among the top granted patent authorities, Omnicell has 44% of its grants in United States(US), 22% in Australia(AU) and 22% in South Korea(KR).

Becton Dickinson and Co could be the strongest competitor for Omnicell

In terms of grant share, Omnicell stands in fourth position among its competitors. Omnicell and Becton Dickinson and Co secured the top positions according to recent patent publication data.

Patents related to healthtech and remote patient monitoring lead Omnicell's portfolio

Omnicell has the highest number of patents in healthtech followed by, remote patient monitoring and industrial automation. For healthtech, nearly 25% of patents were filed and 21% of patents were granted in Q2 2024.

Packaging related patents lead Omnicell portfolio followed by image management, and active and passive safety

Omnicell has highest number of patents in packaging followed by image management, active and passive safety, healthcare it, and enterprise content management.

For comprehensive analysis of Omnicell's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

Be better informed